Latest

  • Scientific Evidence

    Hamm v. Smith: The Limits of Legal Certainty when Science Evolves

    Can states keep IQ testing people sentenced to death until they get the “right” score for execution? What is really at the heart of the Eighth Amendment’s prohibition on executing people who have an intellectual…

    Hamm v. Smith: The Limits of Legal Certainty when Science Evolves

  • Weekly Round-Up

    Petrie-Flom Intern’s Weekly Round-Up: 10/25-11/1

    By Fatima Mirza Recent documents released by Congress have revealed that only six people successfully enrolled in the federal government’s new health care program via the website during the site’s first day. The memoranda indicate…

    Petrie-Flom Intern’s Weekly Round-Up: 10/25-11/1

  • Health Care Reform

    Health Care Fraud in the New Administrative State

    When the Supreme Court decided Loper Bright Enterprises v. Raimondo in June 2024, health care fraud was not foremost on anyone’s mind. 

    Health Care Fraud in the New Administrative State

  • Psychedelics

    States, Not the FDA, Are Winning the Drug War

    President Trump’s recent executive order directing federal agencies to finalize the rescheduling of cannabis from Schedule I to Schedule III marks a watershed moment in American drug policy. 

    States, Not the FDA, Are Winning the Drug War

  • Petrie-Flom Center

    Bill of Health 2025 Year-in-Review

    Social media, pharmaceutical pricing, neurotech, mental health, abortion, psychedelics, and GLP1s generated high interest on the Bill of Health blog this year.

    Bill of Health 2025 Year-in-Review

  • Health Care Finance

    Medical Debt is Bad, But Hospitals Make It So Much Worse

    Medical debt has become a fixture in our health care marketplace, with 41 percent of working-age Americans reportedly struggling to pay their medical bills.

    Medical Debt is Bad, But Hospitals Make It So Much Worse

  • Pharmaceuticals

    The FDA Patent History of Asthma Inhalers

    Even though asthma takes an enormous toll on patients throughout the United States, many struggle to afford asthma medication.

    The FDA Patent History of Asthma Inhalers